DRRX : Summary for DURECT Corporation - Yahoo Finance

U.S. Markets closed

DURECT Corporation (DRRX)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.25-0.02 (-1.57%)
At close: 4:00 PM EST
People also watch:
PTIEDEPOARQLCYTKDVAX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1.27
Open1.28
Bid0.65 x 8000
Ask1.89 x 100
Day's Range1.25 - 1.31
52 Week Range0.99 - 2.55
Volume217,650
Avg. Volume894,517
Market Cap173.23M
Beta1.56
PE Ratio (TTM)-4.98
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cubelast month

    ETF’s with exposure to DURECT Corp. : November 3, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to DURECT Corp. Here are 5 ETF’s with the largest exposure to DRRX-US. Comparing the performance and risk of DURECT Corp. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Marketwiredlast month

    The Life Sciences Report Examines Why the Election Is Not as Relevant to Drug Stocks as You Might Believe

    Due to drug pricing controversies, there has been much concern about how the outcome of the upcoming election will affect pharmaceutical stocks. Dr. Len Yaffe of Stoc*Doc Partners sheds light on the issues ...

  • DURECT Corp. :DRRX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 2, 2016
    Capital Cubelast month

    DURECT Corp. :DRRX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 2, 2016

    Categories: Yahoo Finance Get free summary analysis DURECT Corp. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of DURECT Corp. – Pain Therapeutics, Inc., Johnson & Johnson and Eli Lilly and Company (PTIE-US, JNJ-US and LLY-US) that have also reported for this period. Highlights Summary numbers: Revenues ... Read more (Read more...)